Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

Why the Worries About BlackBerry’s Outlook Are Way Overdone

By Larry Ramer, InvestorPlace Contributor

BlackBerry still has many strong, positive catalysts, and its Q1 results were better than they appeared, making BB stock a buy.

The Outlook for Ocugen Stock Has Deteriorated Further

By Larry Ramer, InvestorPlace Contributor

Phase 3 data on Covaxin wasn't outstanding, and there are indications that demand for additional vaccines in the U.S. and Canada will be low for some time. OCGN remains a good stock to short.

3 Biopharma Penny Stocks That Could be Millionaire Makers

By Larry Ramer, InvestorPlace Contributor

These three biotech penny stocks all have developed drugs that have shown strong indications of success.

Despite Encouraging News, Lordstown’s Shares Still Look Poised to Plunge

By Larry Ramer, InvestorPlace Contributor

With Lordstown still lacking "binding" orders and facing a cash crunch, RIDE stock is likely to tumble sooner or later.

ChargePoint Stock Could Have Competition Problem From EV Maker Networks

By Larry Ramer, InvestorPlace Contributor

With ChargePoint's competition from EV automakers growing fast, this development will likely hit CHPT stock in the not-so-distant future.

Load More